Research frontiers inc (REFR)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Fee income

0

-

0

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fee income

-

-

-

1,450

-

1,488

-

1,525

1,549

1,509

1,507

1,323

1,220

1,236

1,337

1,478

2,037

2,007

2,070

2,077

1,669

1,598

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses

3,747

3,677

3,171

3,078

2,784

3,043

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fee income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,253

2,181

1,957

1,759

1,494

1,184

845

629

583

0

0

0

Operating expenses

-

-

-

-

-

-

-

-

-

-

3,790

3,807

4,036

-

4,388

4,659

4,756

4,742

4,443

4,326

4,561

4,425

5,459

5,684

5,406

6,036

4,426

4,396

4,330

4,101

4,141

3,847

3,732

3,618

3,326

3,238

0

0

0

Research and development

988

1,035

954

937

874

863

861

855

807

799

855

917

1,218

1,417

1,652

1,733

1,564

1,588

1,594

1,591

1,606

1,621

1,871

1,972

2,016

2,203

1,888

1,833

1,830

1,671

1,549

1,521

1,456

1,390

1,385

1,342

0

0

0

Total expenses

4,786

4,764

4,126

4,016

3,659

3,906

3,837

3,866

3,808

3,927

4,646

4,724

5,254

5,504

6,041

6,393

6,320

6,330

6,038

5,917

6,167

6,047

7,331

7,656

7,422

8,240

6,314

6,229

6,160

5,773

5,690

5,368

5,188

5,009

4,712

4,581

0

0

0

Operating loss

-3,285

-3,200

-2,572

-2,565

-2,185

-2,418

-2,440

-2,340

-2,259

-2,418

-3,138

-3,400

-4,034

-4,267

-4,704

-4,915

-4,283

-4,323

-3,967

-3,840

-4,497

-4,448

-5,748

-6,020

-5,660

-6,078

-4,027

-3,976

-3,978

-3,816

-3,931

-3,874

-4,004

-4,163

-4,082

-3,997

0

0

0

Warrant market adjustment

-

652

660

947

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net investment income

59

43

30

19

14

10

6

5

4

4

8

13

20

29

36

39

43

43

40

40

37

35

36

36

38

38

37

30

23

33

35

42

43

29

22

15

0

0

0

Loss before income tax benefit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,782

-3,896

-3,831

-3,961

-4,134

0

0

0

-

-

Income tax benefit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-613

-613

-613

-613

0

0

0

0

-

-

Net loss

-3,629

-3,808

-3,186

-3,476

-2,696

-2,686

-2,720

-2,335

-2,255

-2,413

-3,130

-3,387

-4,014

-4,238

-4,668

-4,875

-4,240

-4,279

-3,927

-3,799

-4,460

-4,413

-5,712

-5,983

-5,621

-6,040

-3,990

-3,945

-3,955

-3,169

-3,283

-3,218

-3,348

-4,134

-4,059

-3,981

0

0

0

Basic and diluted net loss per common share

-0.02

-0.04

-0.01

-0.05

-0.03

-0.02

-0.03

-0.02

-0.03

-0.03

-0.01

-0.02

-0.04

-0.06

-0.02

-0.05

-0.05

-0.08

-0.03

-0.02

-0.05

-0.06

-0.03

-0.05

-0.05

-0.12

-0.04

-0.03

-0.07

-0.04

-0.04

-0.04

-0.04

-0.04

-0.04

-0.05

-0.09

-0.04

-0.04

Weighted average number of common shares outstanding

31,323

31,169

31,065

29,589

28,221

27,697

26,002

25,432

24,691

24,043

24,043

24,043

24,043

24,043

24,043

24,043

24,043

24,085

23,996

24,005

23,944

24,056

23,924

23,554

23,117

23,035

22,916

22,916

22,916

-

20,013

18,907

-

-

-

-

-

-

-

Basic and diluted weighted average number of common shares outstanding (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18,907

-

18,544

18,544

18,518

17,062

17,151